crashbandicootpurple| Hongyuan Pharmaceutical (301246.SZ): There are currently no products prepared through synthetic biology technology

Gelonghui May 27 丨 Hongyuan Pharmaceutical (301246crashbandicootpurple.SZ) said on the investor interaction platformcrashbandicootpurple, the company currently does not prepare it through synthetic biology technologycrashbandicootpurpleproducts. In addition, the "Wuhan R & D Center Expansion Project" implemented by Hubei Hongyuan Chemical Technology Co., Ltd., a wholly-owned subsidiary of the company, will build chemical research platforms including impurity research, crystal form research, synthetic biology research, asymmetric synthesis and continuous flow, as well as preparation research technology platforms such as tablets, capsules, sustained and controlled release and injections. Currently, the project has not yet been completed. The company's R & D progress and development plan have been disclosed in the section 4, Main Business Analysis (4. R & D Investment) of Section 3 "Management Discussion and Analysis" of the 2023 annual report. Please pay attention to the company's regular reports for subsequent progress and specific circumstances.